Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Loss of recognition of SARS-CoV-2 B.1.351 variant spike epitopes but overall preservation of T cell immunity

Catherine Riou, Roanne Keeton, Thandeka Moyo-Gwete, Tandile Hermanus, Prudence Kgagudi, Richard Baguma, Houriiyah Tegally, Deelan Doolabh, Arash Iranzadeh, Lynn Tyers, Hygon Mutavhatsindi, Marius B. Tincho, Ntombi Benede, Gert Marais, Lionel R. Chinhoyi, Mathilda Mennen, Sango Skelem, Elsa du Bruyn, Cari Stek, SA-CIN, Tulio de Oliveira, Carolyn Williamson, Penny L. Moore, Robert J. Wilkinson, Ntobeko A. B. Ntusi, View ORCID ProfileWendy A. Burgers
doi: https://doi.org/10.1101/2021.06.03.21258307
Catherine Riou
1Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa
2Institute of Infectious Disease and Molecular Medicine University of Cape Town; Observatory 7925, South Africa
3Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: c.r.riou@uct.ac.za wendy.burgers@uct.ac.za
Roanne Keeton
2Institute of Infectious Disease and Molecular Medicine University of Cape Town; Observatory 7925, South Africa
3Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thandeka Moyo-Gwete
4National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa
5MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tandile Hermanus
4National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa
5MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prudence Kgagudi
4National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa
5MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Baguma
2Institute of Infectious Disease and Molecular Medicine University of Cape Town; Observatory 7925, South Africa
3Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Houriiyah Tegally
6KwaZulu-Natal Research Innovation and Sequencing Platform; Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deelan Doolabh
3Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arash Iranzadeh
3Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lynn Tyers
3Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hygon Mutavhatsindi
1Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa
2Institute of Infectious Disease and Molecular Medicine University of Cape Town; Observatory 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marius B. Tincho
2Institute of Infectious Disease and Molecular Medicine University of Cape Town; Observatory 7925, South Africa
3Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ntombi Benede
2Institute of Infectious Disease and Molecular Medicine University of Cape Town; Observatory 7925, South Africa
3Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gert Marais
3Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lionel R. Chinhoyi
7Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa
8Hatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town; Observatory 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathilda Mennen
7Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa
8Hatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town; Observatory 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sango Skelem
7Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa
8Hatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town; Observatory 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elsa du Bruyn
1Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa
7Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cari Stek
1Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa
7Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa
9Department of Infectious Diseases, Imperial College London; W12 0NN, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tulio de Oliveira
6KwaZulu-Natal Research Innovation and Sequencing Platform; Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolyn Williamson
1Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa
2Institute of Infectious Disease and Molecular Medicine University of Cape Town; Observatory 7925, South Africa
3Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Penny L. Moore
4National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa
5MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert J. Wilkinson
1Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa
2Institute of Infectious Disease and Molecular Medicine University of Cape Town; Observatory 7925, South Africa
7Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa
9Department of Infectious Diseases, Imperial College London; W12 0NN, UK
10The Francis Crick Institute; London, NW1 1AT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ntobeko A. B. Ntusi
1Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa
7Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa
8Hatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town; Observatory 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wendy A. Burgers
1Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa
2Institute of Infectious Disease and Molecular Medicine University of Cape Town; Observatory 7925, South Africa
3Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wendy A. Burgers
  • For correspondence: c.r.riou@uct.ac.za wendy.burgers@uct.ac.za
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

SARS-CoV-2 variants have emerged that escape neutralization and potentially impact vaccine efficacy. T cell responses play a role in protection from reinfection and severe disease, but the potential for spike mutations to affect T cell immunity is poorly studied. We assessed both neutralizing antibody and T cell responses in 44 South African COVID-19 patients infected either with B.1.351, now dominant in South Africa, or infected prior to its emergence (‘first wave’), to provide an overall measure of immune evasion. We show for the first time that robust spike-specific CD4 and CD8 T cell responses were detectable in B.1.351-infected patients, similar to first wave patients. Using peptides spanning only the B.1.351 mutated regions, we identified CD4 T cell responses targeting the wild type peptides in 12/22 (54.5%) first wave patients, all of whom failed to recognize corresponding B.1.351-mutated peptides (p=0.0005). However, responses to the mutated regions formed only a small proportion (15.7%) of the overall CD4 response, and few patients (3/44) mounted CD8 responses that targeted the mutated regions. First wave patients showed a 12.7 fold reduction in plasma neutralization of B.1.351. This study shows that despite loss of recognition of immunodominant CD4 epitope(s), overall CD4 and CD8 T cell responses to B.1.351 are preserved. These observations may explain why, despite substantial loss of neutralizing antibody activity against B.1.351, several vaccines have retained the ability to protect against severe COVID-19 disease.

One Sentence Summary T cell immunity to SARS-CoV-2 B.1.351 is preserved despite some loss of variant epitope recognition by CD4 T cells.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We acknowledge funding from the South African Medical Research Council and the Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa) which is supported by core funding from the Wellcome Trust [203135/Z/16/Z and 222754]. CR and WAB are supported by the EDCTP2 programme of the European Union (EU) Horizon 2020 programme (TMA2017SF-1951-TB-SPEC to CR and TMA2016SF-1535-CaTCH-22 to WAB). CR is further supported by the National Institutes of Health (NIH) (R21AI148027). PLM is supported by the South African Research Chairs Initiative of the Department of Science and Innovation and the National Research Foundation (Grant No 9834). HM is supported by a National Research Foundation Postdoctoral Fellowship (Grant No 129614). RJW is supported by Francis Crick Institute which receives funding from Wellcome (FC0010218), UKRI (FC0010218) and CRUK (FC0010218). CR and RJW also receive support from Rosetrees Trust (M926). The authors or their institutions did not at any time receive payment or services from any other third party for any aspect of the submitted work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the University of Cape Town Human Research Ethics Committee (HREC: 207/2020 and R021/2020) and electronic or written informed consent was obtained from all participants.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵† South African Cellular Immunology Network (SA-CIN) collaborators and affiliations are listed in the supplementary materials.

Data Availability

The data that support the findings of this study are available from the corresponding authors, WAB and CR, upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted June 06, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Loss of recognition of SARS-CoV-2 B.1.351 variant spike epitopes but overall preservation of T cell immunity
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Loss of recognition of SARS-CoV-2 B.1.351 variant spike epitopes but overall preservation of T cell immunity
Catherine Riou, Roanne Keeton, Thandeka Moyo-Gwete, Tandile Hermanus, Prudence Kgagudi, Richard Baguma, Houriiyah Tegally, Deelan Doolabh, Arash Iranzadeh, Lynn Tyers, Hygon Mutavhatsindi, Marius B. Tincho, Ntombi Benede, Gert Marais, Lionel R. Chinhoyi, Mathilda Mennen, Sango Skelem, Elsa du Bruyn, Cari Stek, SA-CIN, Tulio de Oliveira, Carolyn Williamson, Penny L. Moore, Robert J. Wilkinson, Ntobeko A. B. Ntusi, Wendy A. Burgers
medRxiv 2021.06.03.21258307; doi: https://doi.org/10.1101/2021.06.03.21258307
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Loss of recognition of SARS-CoV-2 B.1.351 variant spike epitopes but overall preservation of T cell immunity
Catherine Riou, Roanne Keeton, Thandeka Moyo-Gwete, Tandile Hermanus, Prudence Kgagudi, Richard Baguma, Houriiyah Tegally, Deelan Doolabh, Arash Iranzadeh, Lynn Tyers, Hygon Mutavhatsindi, Marius B. Tincho, Ntombi Benede, Gert Marais, Lionel R. Chinhoyi, Mathilda Mennen, Sango Skelem, Elsa du Bruyn, Cari Stek, SA-CIN, Tulio de Oliveira, Carolyn Williamson, Penny L. Moore, Robert J. Wilkinson, Ntobeko A. B. Ntusi, Wendy A. Burgers
medRxiv 2021.06.03.21258307; doi: https://doi.org/10.1101/2021.06.03.21258307

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (270)
  • Allergy and Immunology (552)
  • Anesthesia (135)
  • Cardiovascular Medicine (1757)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (312)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (658)
  • Epidemiology (10796)
  • Forensic Medicine (8)
  • Gastroenterology (589)
  • Genetic and Genomic Medicine (2946)
  • Geriatric Medicine (287)
  • Health Economics (534)
  • Health Informatics (1927)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (291)
  • HIV/AIDS (630)
  • Infectious Diseases (except HIV/AIDS) (12515)
  • Intensive Care and Critical Care Medicine (688)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2798)
  • Nursing (151)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1463)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (866)
  • Pharmacology and Therapeutics (366)
  • Primary Care Research (337)
  • Psychiatry and Clinical Psychology (2639)
  • Public and Global Health (5363)
  • Radiology and Imaging (1011)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (726)
  • Rheumatology (330)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (150)
  • Urology (125)